REPORT ID 1536

EMEA (Europe, Middle East and Africa) Mitomycin C Market Report 2017

Publish Date
06-Dec-17
Pages
104
Format
Electronic (PDF)

In this report, the EMEA Mitomycin C market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Mitomycin C for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Mitomycin C market competition by top manufacturers/players, with Mitomycin C sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Kyowa-kirin
    Intas Pharmaceuticals
    Teva
    Bristol-Myers Squibb
    Aspen
    Speciality European Pharma
    Alkem Laboratories
    Varifarma
    APOGEPHA

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    2 Mg
    10 Mg
    40 Mg
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Mitomycin C for each application, including
    Cancer Treatment
    Ophthalmic Use
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Mitomycin C Market Report 2017
1 Mitomycin C Overview
    1.1 Product Overview and Scope of Mitomycin C
    1.2 Classification of Mitomycin C
        1.2.1 EMEA Mitomycin C Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Mitomycin C Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 2 Mg
        1.2.4 10 Mg
        1.2.5 40 Mg
        1.2.6 Other
    1.3 EMEA Mitomycin C Market by Application/End Users
        1.3.1 EMEA Mitomycin C Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Cancer Treatment
        1.3.3 Ophthalmic Use
        1.3.4 Others
    1.4 EMEA Mitomycin C Market by Region
        1.4.1 EMEA Mitomycin C Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Mitomycin C (2012-2022)
        1.5.1 EMEA Mitomycin C Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Mitomycin C Revenue and Growth Rate (2012-2022)

2 EMEA Mitomycin C Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Mitomycin C Market Competition by Players/Manufacturers
        2.1.1 EMEA Mitomycin C Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Mitomycin C Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Mitomycin C Sale Price by Players (2012-2017)
    2.2 EMEA Mitomycin C (Volume and Value) by Type/Product Category
        2.2.1 EMEA Mitomycin C Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Mitomycin C Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Mitomycin C Sale Price by Type (2012-2017)
    2.3 EMEA Mitomycin C (Volume) by Application
    2.4 EMEA Mitomycin C (Volume and Value) by Region
        2.4.1 EMEA Mitomycin C Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Mitomycin C Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Mitomycin C Sales Price by Region (2012-2017)

3 Europe Mitomycin C (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Mitomycin C Sales and Value (2012-2017)
        3.1.1 Europe Mitomycin C Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Mitomycin C Revenue and Growth Rate (2012-2017)
    3.2 Europe Mitomycin C Sales and Market Share by Type
    3.3 Europe Mitomycin C Sales and Market Share by Application
    3.4 Europe Mitomycin C Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Mitomycin C Sales Volume by Countries (2012-2017)
        3.4.2 Europe Mitomycin C Revenue by Countries (2012-2017)
        3.4.3 Germany Mitomycin C Sales and Growth Rate (2012-2017)
        3.4.4 France Mitomycin C Sales and Growth Rate (2012-2017)
        3.4.5 UK Mitomycin C Sales and Growth Rate (2012-2017)
        3.4.6 Russia Mitomycin C Sales and Growth Rate (2012-2017)
        3.4.7 Italy Mitomycin C Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Mitomycin C Sales and Growth Rate (2012-2017)

4 Middle East Mitomycin C (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Mitomycin C Sales and Value (2012-2017)
        4.1.1 Middle East Mitomycin C Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Mitomycin C Revenue and Growth Rate (2012-2017)
    4.2 Middle East Mitomycin C Sales and Market Share by Type
    4.3 Middle East Mitomycin C Sales and Market Share by Application
    4.4 Middle East Mitomycin C Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Mitomycin C Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Mitomycin C Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Mitomycin C Sales and Growth Rate (2012-2017)
        4.4.4 Israel Mitomycin C Sales and Growth Rate (2012-2017)
        4.4.5 UAE Mitomycin C Sales and Growth Rate (2012-2017)
        4.4.6 Iran Mitomycin C Sales and Growth Rate (2012-2017)

5 Africa Mitomycin C (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Mitomycin C Sales and Value (2012-2017)
        5.1.1 Africa Mitomycin C Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Mitomycin C Revenue and Growth Rate (2012-2017)
    5.2 Africa Mitomycin C Sales and Market Share by Type
    5.3 Africa Mitomycin C Sales and Market Share by Application
    5.4 Africa Mitomycin C Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Mitomycin C Sales Volume by Countries (2012-2017)
        5.4.2 Africa Mitomycin C Revenue by Countries (2012-2017)
        5.4.3 South Africa Mitomycin C Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Mitomycin C Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Mitomycin C Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Mitomycin C Sales and Growth Rate (2012-2017)

6 EMEA Mitomycin C Manufacturers/Players Profiles and Sales Data
    6.1 Kyowa-kirin
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Mitomycin C Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Kyowa-kirin Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Intas Pharmaceuticals
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Mitomycin C Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Intas Pharmaceuticals Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Teva
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Mitomycin C Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Teva Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bristol-Myers Squibb
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Mitomycin C Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bristol-Myers Squibb Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Aspen
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Mitomycin C Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Aspen Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Speciality European Pharma
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Mitomycin C Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Speciality European Pharma Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Alkem Laboratories
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Mitomycin C Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Alkem Laboratories Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Varifarma
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Mitomycin C Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Varifarma Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 APOGEPHA
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Mitomycin C Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 APOGEPHA Mitomycin C Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview

7 Mitomycin C Manufacturing Cost Analysis
    7.1 Mitomycin C Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Mitomycin C

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Mitomycin C Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Mitomycin C Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Mitomycin C Market Forecast (2017-2022)
    11.1 EMEA Mitomycin C Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Mitomycin C Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Mitomycin C Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Mitomycin C Price and Trend Forecast (2017-2022)
    11.2 EMEA Mitomycin C Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Mitomycin C Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Mitomycin C Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Mitomycin C Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Mitomycin C Sales Forecast by Type (2017-2022)
    11.7 EMEA Mitomycin C Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer